Skip to Content
  • Rank
  • Previous Rank
  • CEO
    George Paz
  • Address
    1 Express Way, St. Louis, MO 63121
  • Website

Express Scripts shot up this list after a 2012 merger with rival Medco Health Solutions more than doubled the company’s sales. Last year, the prescription drug plan manager’s revenues continued to increase on the whole — up 10.8% — while profits jumped 40.8% to $1.9 billion. Still, sales fell in both the third and fourth quarters as the company contended with losing the business of insurer — and former Medco customer — UnitedHealth Group, which started handling its medical and pharmacy benefit plans in-house in early 2013. Looking ahead, Express Scripts expects its earnings per share to increase between 10% and 20% annually for the next several years thanks to expected growth from its mail order and specialty drug businesses.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Key Financials

$ Millions% change
Total Assets53,548-
Total Shareholder Equity21,837-
Market Value (on March 31, 2014)58,272-

Profit as a % of

Stockholders' Equity8.4

Earnings Per Share

Earnings Per Share ($)2.25
EPS % Change (from 2012)27.8
EPS % Change (5 year)7.9
EPS % Change (10 year)19

Total Return to Investors

Total Return to Investors30.1
Total Return to Investors (5 year, annualized)20.6
Total Return to Investors (10 year, annualized)